Poxy Clinical
Poxy Clinical is a leading RTSM consultancy specializing in User Acceptance Testing (UAT) services for clinical trials. Founded in California and now headquartered in Kendall Square, Cambridge, MA, the company is dedicated to ensuring the accuracy, safety, and efficiency of RTSM systems to support successful clinical trials and patient safety. With extensive experience validated through hundreds of successful go-lives, Poxy Clinical offers customized, high-quality validation and UAT services, leveraging a risk-based methodology and industry best practices. The company collaborates with global sponsors, vendors, and industry leaders to optimize clinical trial success and accelerate time to market.
Industries
Nr. of Employees
small (1-50)
Poxy Clinical
Cambridge, Massachusetts, United States, North America
Products
Guide to Partnering with a UAT Services Provider
Downloadable guide that reviews UAT challenges for IRT-supported trials and outlines best practices for selecting and working with a UAT provider, including GAMP-5 considerations.
Webinar: UAT and Risk Mitigation (recording)
Recorded webinar featuring discussions on evolving UAT practices, risk-based thinking, and protocol-aligned testing with industry experts.
Guide to Partnering with a UAT Services Provider
Downloadable guide that reviews UAT challenges for IRT-supported trials and outlines best practices for selecting and working with a UAT provider, including GAMP-5 considerations.
Webinar: UAT and Risk Mitigation (recording)
Recorded webinar featuring discussions on evolving UAT practices, risk-based thinking, and protocol-aligned testing with industry experts.
Services
End-to-end user acceptance testing engagement covering UAT planning, test script development, test execution, issue management, and delivery of inspection-ready validation reports.
Protocol review, development of comprehensive positive and negative test scenarios, and data setup strategies to ensure realistic testing coverage.
Independent third-party representation during UAT to act on behalf of the sponsor, coordinate with IRT vendors, and manage issue resolution to closure.
End-to-end user acceptance testing engagement covering UAT planning, test script development, test execution, issue management, and delivery of inspection-ready validation reports.
Protocol review, development of comprehensive positive and negative test scenarios, and data setup strategies to ensure realistic testing coverage.
Independent third-party representation during UAT to act on behalf of the sponsor, coordinate with IRT vendors, and manage issue resolution to closure.
Expertise Areas
- User acceptance testing for IRT/RTSM
- Risk-based computer systems validation (GAMP-5 alignment)
- Test script development and negative-scenario testing
- Inspection-ready audit documentation and reporting
Key Technologies
- Interactive Response Technology (IRT) / Randomization and Trial Supply Management (RTSM) systems
- Configurable eClinical system implementations
- Risk-based validation frameworks (GAMP-5)
- Protocol-driven test script frameworks
News & Updates
Poxy Clinical sponsored the OCT 2023 event in Boston, bringing together clinical trial professionals to explore new technologies and optimize outsourcing operations.
Webinars featuring insights from industry experts on best practices for UAT and risk mitigation in clinical trials, including collaborations with 4G Clinical and Vir Biotechnologies.
A comprehensive guide to help sponsors effectively partner with third-party UAT providers, emphasizing best practices, roles, and expectations.
An article discussing the dangers of handling UAT in-house or with vendors that have conflicts of interest, and the benefits of outsourcing to experienced third-party providers.
Susan Vong, President of Poxy Clinical, was recognized by the Boston Mayor’s Office of Women’s Advancement for her contributions to health and clinical trial systems.
Poxy Clinical sponsored the OCT 2023 event in Boston, bringing together clinical trial professionals to explore new technologies and optimize outsourcing operations.
Webinars featuring insights from industry experts on best practices for UAT and risk mitigation in clinical trials, including collaborations with 4G Clinical and Vir Biotechnologies.
A comprehensive guide to help sponsors effectively partner with third-party UAT providers, emphasizing best practices, roles, and expectations.
An article discussing the dangers of handling UAT in-house or with vendors that have conflicts of interest, and the benefits of outsourcing to experienced third-party providers.
Susan Vong, President of Poxy Clinical, was recognized by the Boston Mayor’s Office of Women’s Advancement for her contributions to health and clinical trial systems.